California Public Employees Retirement System Sells 67,990 Shares of Cigna Group $CI

Posted by ABMN Staff on Mar 16th, 2026

California Public Employees Retirement System cut its stake in shares of Cigna Group (NYSE:CI – Free Report) by 9.0% during the third quarter, HoldingsChannel.com reports. The fund owned 690,200 shares of the health services provider’s stock after selling 67,990 shares during the quarter. California Public Employees Retirement System’s holdings in Cigna Group were worth $198,950,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Norges Bank bought a new position in Cigna Group in the second quarter worth approximately $1,110,426,000. Capital Research Global Investors raised its position in Cigna Group by 140.2% during the 3rd quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock valued at $916,434,000 after purchasing an additional 1,855,897 shares in the last quarter. Ameriprise Financial Inc. raised its position in Cigna Group by 54.5% during the 3rd quarter. Ameriprise Financial Inc. now owns 2,136,311 shares of the health services provider’s stock valued at $615,781,000 after purchasing an additional 753,865 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its holdings in shares of Cigna Group by 24.4% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 2,508,740 shares of the health services provider’s stock worth $829,339,000 after buying an additional 492,045 shares during the period. Finally, Balyasny Asset Management L.P. grew its position in shares of Cigna Group by 1,057.2% during the 2nd quarter. Balyasny Asset Management L.P. now owns 404,753 shares of the health services provider’s stock worth $133,803,000 after buying an additional 369,775 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Price Performance

Shares of CI stock opened at $267.15 on Monday. The stock’s 50-day moving average is $279.60 and its 200 day moving average is $282.70. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.74. The company has a market cap of $70.40 billion, a P/E ratio of 12.04, a PEG ratio of 0.93 and a beta of 0.27.

Cigna Group (NYSE:CI – Get Free Report) last announced its earnings results on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. The business had revenue of $72.50 billion during the quarter, compared to the consensus estimate of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The firm’s revenue was up 10.4% on a year-over-year basis. During the same period in the previous year, the company posted $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Research analysts predict that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Thursday, March 5th will be paid a dividend of $1.56 per share. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date is Thursday, March 5th. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. Cigna Group’s dividend payout ratio (DPR) is presently 28.13%.

Analyst Upgrades and Downgrades

CI has been the topic of several research reports. Sanford C. Bernstein upgraded Cigna Group from a “market perform” rating to an “outperform” rating and raised their price target for the company from $307.00 to $358.00 in a research note on Thursday. UBS Group reiterated a “buy” rating and set a $375.00 target price on shares of Cigna Group in a report on Monday, February 9th. Leerink Partners raised their target price on shares of Cigna Group from $270.00 to $297.00 and gave the company a “market perform” rating in a research report on Friday, February 6th. Royal Bank Of Canada reduced their price target on shares of Cigna Group from $344.00 to $333.00 and set an “outperform” rating for the company in a report on Friday, February 6th. Finally, Piper Sandler lowered their price target on shares of Cigna Group from $374.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, March 3rd. One investment analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $333.11.

View Our Latest Stock Report on Cigna Group

Key Headlines Impacting Cigna Group

Here are the key news stories impacting Cigna Group this week:

Positive Sentiment: Sanford C. Bernstein upgraded Cigna to “outperform” and raised its price target to $358, citing PBM reform as a clearing event and improved outlook for Evernorth — a catalyst for multiple analysts to raise estimates. Bernstein upgrades CVS and Cigna, citing PBM reform as key clearing event
Positive Sentiment: Zacks notes CI trades below the industry P/E and highlights Evernorth growth, steady earnings beats and buybacks as supports for the investment case — a valuation/earnings combo that helps explain buying interest. Cigna Stock Trades Below Industry P/E: Is It Worth Holding Now?
Neutral Sentiment: A valuation review highlights recent share-price weakness versus the specialty-pharmacy growth narrative — useful context for investors weighing whether current discounts already reflect execution risks. Evaluating Cigna Group (CI) Valuation After Recent Share Price Weakness And Specialty Pharmacy Growth Narrative
Neutral Sentiment: A head-to-head comparison with CVS frames Cigna as the play for stronger earnings quality and capital discipline, while reminding long-term investors to consider income, stability and valuation differences when choosing exposure. CVS vs Cigna: Which Healthcare Giant Belongs in Your Retirement Portfolio?
Neutral Sentiment: Zacks’ broader industry outlook continues to single out major HMOs (including Cigna) as key players in a sector balancing tech-enabled growth and policy/operational headwinds. Zacks Industry Outlook Highlights UnitedHealth, The Cigna, Humana and Centene
Negative Sentiment: Barclays and commentators warn that the timing of a CEO change could surprise investors and introduce strategic/operational uncertainty during a critical execution window. Management transition risk may weigh on sentiment until plans are clearer. The Cigna Group (CI) CEO Change Timing May Come As Surprise to Some Investors, According to Barclays
Negative Sentiment: Industry pieces flag escalating medical costs, nursing shortages and margin pressure as sector-wide risks that could blunt near-term earnings leverage for HMOs, including Cigna. 4 HMO Stocks to Watch Despite Escalating Costs, Nursing Shortage

Insider Buying and Selling

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the sale, the insider directly owned 32,647 shares in the company, valued at $9,432,044.77. This trade represents a 6.60% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the transaction, the insider directly owned 5,670 shares in the company, valued at $1,638,119.70. This represents a 23.26% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 0.70% of the company’s stock.

Cigna Group Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.